Irini Gerogianni

Dr. Irini Gerogianni


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008
Verified
Journal Article
Closed access
IGIrini Gerogianni
Irini Gerogianni
MPM Papala
M Papala
KKKostas Kostikas
Kostas Kostikas
EPE Petinaki
E Petinaki
KGK I Gourgoulianis
K I Gourgoulianis

Verified
Journal Article
Open access
PDF file
Ourania S. KotsiouOurania S. Kotsiou
Ourania S. Kotsiou
KKKaterina Katsanaki
Katerina Katsanaki
ATAikaterini Tsingene
Aikaterini Tsingene
SPSophia Papathanasiou
Sophia Papathanasiou
ERErasmia Rouka
Erasmia Rouka
ITIrene Tsilioni
Irene Tsilioni
Background: Only one study has reported the presence of extracellular vesicles (EVs) in COPD patients’ sputum. Thus, we aimed to isolate and characterize EVs from COPD and healthy individuals’ sputum. Methods: A total of 20 spontaneous sputum samples from COPD patients (m/f: 19/1) and induced sputum samples from healthy controls (m/f: 8/2) were used for EV isolation. The sputum supernatants were resuspended in PBS, precleared by centrifugation at 800× g for 10 min at 4 °C, and passed through a 0.22 μm filter (Millipore, Burlington, MA, USA). EVs were isolated by a standard membrane affinity spin column method (exoEasy maxi kit, Qiagen, Hilden, Germany). The EVs were then characterized by assessing their morphology and size using Transmission Electron Microscopy (TEM) and determining the CD9 and CD81 EV-markers with Western blot analysis. Results: The EVs had a spherical shape and their mean diameter in the COPD patients was significantly greater than in the controls. Enrichment of the EV markers, CD9 and CD81, were detected in both the healthy and COPD individuals. Total EV-associated protein was significantly increased in the COPD patients compared to the controls. ROC analysis showed that total EV-associated protein in the sputum could be used to differentiate between the controls and COPD patients, with a sensitivity of 80% and a specificity of 70% at a cut-off point of 55.59 μg/mL (AUC = 0.8150). Conclusions: EVs were detectable in both the COPD and healthy individuals’ sputum. The ratio of EVs in the 150–200 nm range was twice as high in the COPD patients than in the controls. The COPD patients’ sputum contained increased total EV-associated protein as compared to controls, highlighting their value as a new source of specific exoproteins.

28 March 2016 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
EDEleni Dovriki
Eleni Dovriki
IGIrini Gerogianni
Irini Gerogianni
Efthymia PetinakiEfthymia Petinaki
Efthymia Petinaki
Christos HadjichristodoulouChristos Hadjichristodoulou
Christos Hadjichristodoulou
APAgelos Papaioannou
Agelos Papaioannou
Konstantinos I. GourgoulianisKonstantinos I. Gourgoulianis
Konstantinos I. Gourgoulianis

2 October 2023 in Medicina
Verified
Journal Article
Open access
PDF file
NNNiki Ntavari
Niki Ntavari
VSVasiliki Syrmou
Vasiliki Syrmou
KTKonstantinos Nikolaos Tourlakopoulos
Konstantinos Nikolaos Tourlakopoulos
Foteini MalliFoteini Malli
Foteini Malli
IGIrini Gerogianni
Irini Gerogianni
Ioannis PantazopoulosIoannis Pantazopoulos
Ioannis Pantazopoulos
Cutaneous tuberculosis (TB) is still a major public health problem worldwide. Tuberculosis verrucosa cutis (TBVC) is a cutaneous form of exogenous TB caused by exogenous reinfection in previously sensitized individuals. TBVC typically presents as a unifocal condition. Multifocal cutaneous lesions without any other tubercular foci are extremely rare in exogenous TB and few cases are reported in the literature. We describe the first case of multifocal TBVC in an 81-year-old Greek man. In total, 14 cases of multifocal TBVC have been reported in the literature (8 males and 6 females), with mean age 47.64 years (SD = 20.75) and mean time to diagnosis of 9.69 years (SD = 15.31). Most cases (11/12) responded rapidly to treatment, implying the accuracy of diagnosis, while no one was reported to be immunocompromised. Finally, in 10 cases (71.4%), history of skin microtrauma was reported (related either to daily life habits or to professional praxis), confirming it as the main risk factor. The tuberculin skin test was positive in 10 cases and tissue culture for mycobacteria was negative in all cases. TBVC can present with multiple lesions, even in countries where TB prevalence is not high, especially in patients with history of skin abrasions. Prompt specialist assessment can expedite the establishment of diagnosis.

1 March 2008 in Respirology
Verified
Journal Article
Closed access
PDF file
IGIrini Gerogianni
Irini Gerogianni
MPMaria Papala
Maria Papala
DKDimitra Klapsa
Dimitra Klapsa
EZElias Zinzaras
Elias Zinzaras
EPEfi Petinaki
Efi Petinaki
KGK. I. Gourgoulianis
K. I. Gourgoulianis

3 December 2009 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
IGIrini Gerogianni
Irini Gerogianni
MPMaria Papala
Maria Papala
KKKostas Kostikas
Kostas Kostikas
MIMaria Ioannou
Maria Ioannou
AKArgiroula-Vasiliki Karadonta
Argiroula-Vasiliki Karadonta
Konstantinos I. GourgoulianisKonstantinos I. Gourgoulianis
Konstantinos I. Gourgoulianis
In cases of patients with disseminated lymphadenopathy, the differential diagnosis has to include both benign and malignant causes, including sarcoidosis, metastatic disease, lymphoma and, although rarely present, tuberculosis. Tuberculosis is still one of the most frequently occurring infectious diseases worldwide. However, disseminated mycobacterial lymphadenitis is rare in immunocompetent patients.